A 62-year-old woman is evaluated in the hospital for sudden-onset right leg pain and swelling. She was admitted 6 days ago for a pulmonary embolism and has been receiving a continuous intravenous infusion of unfractionated heparin. Today, her platelet count is 65,000/mm³, representing a significant drop from her admission baseline of 240,000/mm³. Lower extremity venous Doppler ultrasound reveals a new acute deep vein thrombosis in the right femoral vein. The 4Ts score is calculated and indicates a high clinical probability of heparin-induced thrombocytopenia (HIT).
Arrange the following steps for the diagnosis and long-term management of this patient in the most appropriate chronological order.
- 1Discontinue the unfractionated heparin infusion and eliminate all heparin-containing flushes
- 2Initiate therapeutic anticoagulation with a non-heparin agent (e.g., argatroban or bivalirudin)
- 3Confirm the diagnosis with a functional serotonin release assay following a positive initial anti-PF4/heparin immunoassay
- 4Transition to maintenance oral warfarin therapy once the platelet count recovers to >150,000/mm³
Answer
The correct chronological sequence is to first discontinue all heparin exposure, immediately initiate a direct thrombin inhibitor, subsequently confirm the diagnosis with specific laboratory assays, and finally transition to warfarin only after platelet count recovery.
The definitive management sequence for high-probability heparin-induced thrombocytopenia (HIT) prioritizes immediate cessation of heparin and prompt initiation of a non-heparin anticoagulant (such as a direct thrombin inhibitor) to prevent catastrophic thrombosis. Diagnostic confirmation follows empirically initiated therapy. Warfarin is delayed until the platelet count normalizes.
Step-by-Step Solution
Key Concept
Management algorithm for Heparin-Induced Thrombocytopenia (HIT)